A multi-center survey of age of sexual debut and sexual behavior in Chinese women: Suggestions for optimal age of human papillomavirus vaccination in China

Cancer Epidemiology

Volumn 36, Issue 4, 2012, Pages 384-390

  Zhao, Fang Hui ^a   Tiggelaar, Sarah M ^a,b   Hu, Shang Ying ^a   Xu, Li Na ^c   Hong, Ying ^d   Niyazi, Mayinuer ^e   Gao, Xiao Hong ^f   Ju, Li Rong ^c   Zhang, Li Qin ^g   Feng, Xiang Xian ^h   Duan, Xian Zhi ⁱ   Song, Xiu Ling ^j   Wang, Jing ^k   Yang, Yun ^l   Li, Chang Qing ^m   Liu, Jia Hua ⁿ   Liu, Ji Hong ^o   Lu, Yu Bo ^p   Li, Li ^q   Zhou, Qi ^r   Liu, Jin feng ^s   Zhao, Na ^f   Schmidt, Johannes E ^t   Qiao, You Lin ^a   more..

^a CANCER HOSPITAL   (China)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^e PEOPLE S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION   (China)

^f DALIAN MEDICAL UNIVERSITY   (China)

^g TIANJIN MEDICAL UNIVERSITY   (China)

^h Shanxi Province Chang Zhi Medical University   (China)

ⁱ Inner Mongolia Autonomous Region Hospital   (China)

^j Feicheng People's Hospital in Shandong Province   (China)

^k HUNAN CANCER HOSPITAL   (China)

^l YICHUN UNIVERSITY   (China)

^m Xinmi Maternal and Child Care Hospital   (China)

ⁿ People's Hospital of Fujian Province   (China)

^o SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^p Cancer Hospital of Yunnan Province   (China)

^q THIRD MILITARY MEDICAL UNIVERSITY   (China)

^r Cancer Hospital of Chongqing   (China)

^s GANSU PROVINCIAL MATERNITY AND CHILD CARE HOSPITAL   (China)

^t Glaxo Smith Kline Biologicals   (China)

more..

Author keywords

Cervical cancer; China; HPV vaccine; Human papillomavirus; Sexual debut

Indexed keywords

ABORTION; ADOLESCENT; ADULT; ARTICLE; CHINA; CHINESE; CONDOM; CONTRACEPTION; EPIDEMIOLOGY; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MENARCHE; MULTICENTER STUDY; OCCUPATION; PERINEUM; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; RURAL AREA; SEXUAL BEHAVIOR; SEXUAL DEBUT; SEXUAL INTERCOURSE; SEXUALITY; URBAN AREA; VACCINATION; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; CHINA; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84863449679     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.01.009     Document Type: Article

References (30)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, E-pub.
2. Shi J.F., Qiao Y.L., Smith J.S., Dondog B., Bao Y.P., Dai M., et al. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine 2008, 26(Suppl. 12):M53-M59.
3. Zhang Y.Z., Ma J.F., Zhao F.H., Xiang X.E., Ma Z.H., Shi Y.T., et al. Three-year follow-up results of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an alternative screening method for cervical cancer in rural areas. Chin J Cancer 2010, 29(1):4-8.
4. Zhao F.H., Hu S.Y., Zhang S.W., Chen W.Q., Qiao Y.L. Cervical cancer mortality in 2004-2005 and changes during last 30 years in China. Zhonghua Yu Fang Yi XueZaZhi 2010, 44(5):408-412.
5. Burchell A.N., Winer R.L., de Sanjose S., Franco E.L. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006, 24(Suppl. 3):S52-S61.
6. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348(6):518-527.
7. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer world-wide. J Pathol 1999, 189(1):12-19.
8. zurHausen H. Oncogenic DNA viruses. Oncogene 2001, 20(54):7820-7823.
9. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., et al. Proof of Principle Study Investigators. A controlled trial of human papillomavirus type 16 vaccine. N Engl J Med 2002, 347(21):1645-1651.
10. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005, 6(5):271-278.
11. Goldie S.J., Kohli M., Grima D., Weinstein M.C., Wright T.C., Bosch F.X., et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 2004, 96:604-615.
12. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004, 364:1757-1765.
13. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002, 51:1-78.
14. Li J., Li L.K., Ma J.F., Wei L.H., Niyazi M., Li C.Q., et al. Knowledge and attitudes about human papillomavirus(HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine 2009, 27(8):1210-1215.
15. Ministry of Health (MOH) Chinese Health Statistics Yearbook 2007, Peking Union Medical Press, Beijing, China, 337.
16. Crochard A., Luyts D., di Nicola S.M., Goncalves A.G. Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs. Gynecol Oncol 2009, 115:S7-S14.
17. Zaba B., Pisani E., Slaymaker E., Boerma J.T. Age at first sex: understanding recent trends in African demographic surveys. Sex Transm Infect 2004, ii28-ii35.
18. Sellors J.W., Karwalajtys T.L., Kaczorowski J., Mahony J.B., Lytwyn A., Chong S., et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003, 168(4):421-425.
19. Hildesheim A., Herrero R., Wacholder S., Rodriquez A.C., Solomon D., Bratti M.C., et al. Effect of human papillomavirus 16, 18 L1 virus-like particle vaccine among young women with preexisting infection: a randomized trial. JAMA 2007, 298:743-753.
20. Panatto D., Amicizia D., Lugarini J., Sasso T., Sormani M.P., Badolati G., et al. Sexual behavior in Ligurian (Northern Italy) adolescents and young people; suggestions for HPV vaccination policies. Vaccine 2009, 27:A6-A10.
21. Winer R.L., Hughes J.P., Feng Q., O'Reilly S., Kiviat N.B., Holmes K.K., et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006, 354:2645-2654.
22. Holmes K.K., Levine R., Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004, 82:454-461.
23. Hernandez B.Y., Wilkens L.R., Zhu X., Thompson P., McDuffle K., Shvetsov Y.B., et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008, 14:888-894.
24. Jin X.Y., Li S.Z., Feldman M.W. Marriage form and age at first marriage: a comparative study in three counties in contemporary rural China. Soc Biol 2005, 52:18-46.
25. Harper D.H., Franco E.L., Wheeler C.M., Mosicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial. Lancet 2006, 367:1247-1255.
26. Moscicki A.B. Impact of HPV infection in adolescent populations. J Adolesc Health 2005, 37(Suppl. 6):S3-S9.
27. Kjær S.K., Frederiksen K., Munk C., Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010, 102(19):1478-1488.
28. Liu D., Ng M.L., Zhou L.P., Haeberle E.J. Sexual behavior in modern China: report on the nation-wide survey of 20,000 men and women 1997, Continuum, New York, 586.
29. Gu C., Chan C.W.H., Twinn S. How sexual history and knowledge of cervical cancer and screening influence Chinese women's screening behavior in mainland China. Cancer Nurs 2010, 33(6):445-453.
30. Wang W., Wei C., Buchholz M.E., Martin M.C., Smith B.D., Huang Z.J., et al. Prevalence and risks for sexually transmitted infections among a national sample of migrants versus non-migrants in China. Int J STD AIDS 2010, 21:410-415.